HIF1A and hepatocellular carcinoma: In this follow-up study, we could demonstrate that the inhibition of CRM1 by Selinexor decreases the intranuclear HIF-1α protein level in human osteosarcoma and human hepatocellular carcinoma cells accompanied by an enhanced radiation response in both cell lines.